WNT1/ROR2 pathway enhances the Triple‐Negative breast cancer invasion, migration, and Epithelial‐Mesenchymal transition
Journal of Biochemical and Molecular Toxicology · 2024
DOI: 10.1002/jbt.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Xin Jin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuj, Zhejiang, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Triple Negative Breast Neoplasms, Receptor Tyrosine Kinase-like Orphan Receptors, Cell Movement. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Zhejiang Medical and Health Science and Technology Plan Project, Shaoxing Health Science and Technology Plan Project, Zhuji Medical and Health Science and Technology Plan Project.
Abstract (Originalsprache)
It has been evidenced that ROR2 influences the growth of many tumors, including non‐small cell lung cancer, osteosarcoma, and breast cancer. This research examined the effect of the WNT1/ROR2 signaling pathway on the progression of triple‐negative breast cancer (TNBC). Bioinformatics analysis results demonstrated that ROR2 had a higher messenger RNA (mRNA) expression level in TNBC tissues and was positively correlated with poor patient prognosis. Western blot analysis (WB) and quantitative reverse transcription polymerase chain reaction demonstrated that TNBC cells had relatively higher ROR2 mRNA and protein levels than normal cell lines. Transwell and Cell Counting Kit‐8 (CCK‐8) assay further proved that downregulating ROR2 expression dramatically slowed the MDA‐MB‐231 cell progression. WB detection of epithelial‐mesenchymal transition (EMT)‐related proteins suggested that knocking down ROR2 could alleviate the EMT tendency of cancer cells. The WNT1/ROR2 signaling pathway could be inhibited by the WNT inhibitor pyrvinium pamoate (PP). Experiments on in vitro cell functional recovery have demonstrated that PP could restore malignant phenotypes caused by ROR2 overexpression. Finally, the mouse model experiments further validated the anticancer effect of PP on TNBC. Generally speaking, the malignant progression of TNBC could be stimulated by the WNT1/ROR2 signaling pathway which can be inhibited by PP, suggesting the potential value of PP in controlling TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuj, Zhejiang, China.
- Department of Hematology, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuj, Zhejiang, China.
- Department of Pathology, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuj, Zhejiang, China.
Förderung
- Zhejiang Medical and Health Science and Technology Plan Project
- Shaoxing Health Science and Technology Plan Project
- Zhuji Medical and Health Science and Technology Plan Project
Zitieren
APA
Jin, X., Fu, C., Chen, Y., Jin, C., Jin, G., & Yan, J. (2024). WNT1/ROR2 pathway enhances the Triple‐Negative breast cancer invasion, migration, and Epithelial‐Mesenchymal transition. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70010
Vancouver
Jin X, Fu C, Chen Y, Jin C, Jin G, Yan J. WNT1/ROR2 pathway enhances the Triple‐Negative breast cancer invasion, migration, and Epithelial‐Mesenchymal transition. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.70010
BibTeX
@article{Jin2024,
author = {Jin, Xin and Fu, Chunlan and Chen, Yusa and Jin, Canguang and Jin, Gaopei and Yan, Junfeng},
title = {WNT1/ROR2 pathway enhances the Triple‐Negative breast cancer invasion, migration, and Epithelial‐Mesenchymal transition},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2024},
doi = {10.1002/jbt.70010}
}
EUVIMED